ホーム
探索
nav.journalClub
トレンド
その他
synapse
⌘+K
言語
日本語
日本語
Disease modifying therapies for Alzheimer's disease | Synapse
March 3, 2026
Disease modifying therapies for Alzheimer's disease
CC
Christopher Chen
Key Points
Therapies aim to modify the disease course rather than just manage symptoms.
Specific biomarkers are critical in assessing therapy effectiveness, offering insights into disease mechanisms.
Assessment of current interventions identifies gaps, emphasizing the need for innovative strategies.
Future research should focus on refining pathways and understanding individual responses to therapies.
Mark Helpful
Like
Save
Bookmark
Relay
Share
Cite This Study
Copy
Christopher Chen (Mon,) studied this question.
synapsesocial.com/papers/69a75f61c6e9836116a2ab6c
https://doi.org/https://doi.org/10.1016/j.jns.2025.123828
Mark Helpful
Like
Save
Bookmark
Relay
Share